Tissue and Cell Extraction and Purification |
|
EP10011 |
Neuromics |
100 Tests |
EUR 444.6 |
All Competitors Laboratories manufactures the antibodyb reagents distributed by Genprice. The Antibodyb reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact All Competitors. Other Antibodyb products are available in stock. Specificity: Antibodyb Category:
JBS True Blue |
|
MiTeGen |
300 µl |
EUR 16 |
|
Description: JBS True Blue |
Porcine True insulin ELISA kit |
|
BlueGene |
96T |
EUR 700 |
|
Description: ELISA |
Goat True insulin ELISA kit |
|
BlueGene |
96T |
EUR 700 |
|
Description: ELISA |
Serum / Plasma information
CEA Antibody-Biotin |
|
E63C00304 |
EnoGene |
100ug |
EUR 295 |
|
Description: Available in various conjugation types. |
CEA Antibody-Biotin |
|
MBS850886-01mg |
MyBiosource |
0.1mg |
EUR 370 |
CEA Antibody-Biotin |
|
MBS850886-01mLAF405L |
MyBiosource |
0.1mL(AF405L) |
EUR 465 |
CEA Antibody-Biotin |
|
MBS850886-01mLAF405S |
MyBiosource |
0.1mL(AF405S) |
EUR 465 |
CEA Antibody-Biotin |
|
MBS850886-01mLAF610 |
MyBiosource |
0.1mL(AF610) |
EUR 465 |
CEA Antibody-Biotin |
|
MBS850886-01mLAF635 |
MyBiosource |
0.1mL(AF635) |
EUR 465 |
Anti-BSA Antibody [2-B8] |
|
M0809-3 |
HUABIO |
100ul |
EUR 210 |
|
|
|
Description: Albumin is a soluble, monomeric protein has molecular weight of c. 66 kDa. It is primarily as a carrier protein for steroids, fatty acids, and thyroid hormones and plays a role in stabilizing extracellular fluid volume. Serum albumin protein has numerous biochemical applications including ELISAs, immunoblots, and immunohistochemistry. It is also used as a nutrient in cell and microbial culture. |
TIGIT Antibody [3B5] |
|
MBS154590-01mg |
MyBiosource |
0.1mg |
EUR 500 |
TIGIT Antibody [3B5] |
|
MBS154590-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2230 |
LAG3 Antibody [6B12] |
|
MBS154613-01mg |
MyBiosource |
0.1mg |
EUR 500 |
LAG3 Antibody [6B12] |
|
MBS154613-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2230 |
TIM-3 Antibody [1B10] |
|
MBS154633-01mg |
MyBiosource |
0.1mg |
EUR 500 |
TIM-3 Antibody [1B10] |
|
MBS154633-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2230 |
GPI antibody | 1B7D7 |
|
MBS226356-01mL |
MyBiosource |
0.1mL |
EUR 485 |
GPI antibody | 1B7D7 |
|
MBS226356-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2015 |
RUNX3 antibody | 2B3 |
|
MBS226469-01mL |
MyBiosource |
0.1mL |
EUR 485 |
RUNX3 antibody | 2B3 |
|
MBS226469-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2015 |
SMAD4 antibody | 1B6 |
|
MBS226479-01mL |
MyBiosource |
0.1mL |
EUR 485 |
SMAD4 antibody | 1B6 |
|
MBS226479-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2015 |
STAT3 antibody | 3B5 |
|
MBS226488-01mL |
MyBiosource |
0.1mL |
EUR 485 |
STAT3 antibody | 3B5 |
|
MBS226488-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2015 |
TIGIT Antibody [3B5] |
|
RF16053-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
|
|
Description: TIGIT Antibody: The T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a member of the PVR (poliovirus receptor) family of immunoglobin proteins. It is expressed on several classes of T cells including follicular B helper T cells (TFH). TIGIT has been shown to bind PVR with high affinity; this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses (1). Similar to other immune checkpoint proteins such as PD-1, TIGIT is upregulated on exhausted T cells in chronic viral infections and cancer. Blockade of both TIGIT and PD-1 pathways leads to tumor rejection in mice suggesting that it may be of therapeutic use against cancer (2). |
TIGIT Antibody [3B5] |
|
RF16053-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
|
|
Description: TIGIT Antibody: The T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a member of the PVR (poliovirus receptor) family of immunoglobin proteins. It is expressed on several classes of T cells including follicular B helper T cells (TFH). TIGIT has been shown to bind PVR with high affinity; this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses (1). Similar to other immune checkpoint proteins such as PD-1, TIGIT is upregulated on exhausted T cells in chronic viral infections and cancer. Blockade of both TIGIT and PD-1 pathways leads to tumor rejection in mice suggesting that it may be of therapeutic use against cancer (2). |
LAG3 Antibody [6B12] |
|
RF16086-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
|
|
Description: The lymphocyte activation gene-3 (LAG3) is a member of the immunoglobulin superfamily and binds MHC class II with high affinity (1), negatively regulating T-cell function and homeostasis (2). It is expressed in B, T, and NK cells, monocytes, and dendritic cells (3), and acts to regulate T cell expansion (4). LAG3 is also an important immune checkpoint protein, with anti-LAG3 antibodies activating T effector cells and affecting regulatory T cell functions. Furthermore LAG3 appears to act in a synergistic fashion with PD-1/PD-L1, suggesting that a dual antibody approach may prove useful in cancer immunotherapy. |
LAG3 Antibody [6B12] |
|
RF16086-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
|
|
Description: The lymphocyte activation gene-3 (LAG3) is a member of the immunoglobulin superfamily and binds MHC class II with high affinity (1), negatively regulating T-cell function and homeostasis (2). It is expressed in B, T, and NK cells, monocytes, and dendritic cells (3), and acts to regulate T cell expansion (4). LAG3 is also an important immune checkpoint protein, with anti-LAG3 antibodies activating T effector cells and affecting regulatory T cell functions. Furthermore LAG3 appears to act in a synergistic fashion with PD-1/PD-L1, suggesting that a dual antibody approach may prove useful in cancer immunotherapy. |
TIM3 Antibody [1B10] |
|
RF16107-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
|
|
Description: The immune checkpoint protein TIM3 is a member of the immunoglobulin superfamily and TIM family of proteins that was initially identified as a specific marker of fully differentiated IFN-γ producing CD4 T helper 1 (Th1) and CD8 cytotoxic cells. It is a Th1-specific cell surface protein that regulates macrophage activation and negatively regulates Th1-mediated auto- and alloimmune responses, and is also highly expressed on regulatory T cells, monocytes, macrophages, and dendritic cells (1). TIM3 and PD-1 are co-expressed on most CD4 and CD8 T cells infiltrating solid tumors or in hematologic malignancy in mice; blocking TIM3 in conjugation with a PD-1 blockade increases the functionality of exhausted T cells and synergizes with to inhibit tumor growth (2,3). |
TIM3 Antibody [1B10] |
|
RF16107-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
|
|
Description: The immune checkpoint protein TIM3 is a member of the immunoglobulin superfamily and TIM family of proteins that was initially identified as a specific marker of fully differentiated IFN-γ producing CD4 T helper 1 (Th1) and CD8 cytotoxic cells. It is a Th1-specific cell surface protein that regulates macrophage activation and negatively regulates Th1-mediated auto- and alloimmune responses, and is also highly expressed on regulatory T cells, monocytes, macrophages, and dendritic cells (1). TIM3 and PD-1 are co-expressed on most CD4 and CD8 T cells infiltrating solid tumors or in hematologic malignancy in mice; blocking TIM3 in conjugation with a PD-1 blockade increases the functionality of exhausted T cells and synergizes with to inhibit tumor growth (2,3). |
TIGIT Antibody [2B5] |
|
SD8824-002mg |
ProSci |
0.02 mg |
EUR 253.22 |
|
|
|
Description: TIGIT Antibody: The T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a member of the PVR (poliovirus receptor) family of immunoglobin proteins. It is expressed on several classes of T cells including follicular B helper T cells (TFH). TIGIT has been shown to bind PVR with high affinity; this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses (1). Similar to other immune checkpoint proteins such as PD-1, TIGIT is upregulated on exhausted T cells in chronic viral infections and cancer. Blockade of both TIGIT and PD-1 pathways leads to tumor rejection in mice suggesting that it may be of therapeutic use against cancer (2). |